Shuffler News
  • Home
  • Shuffles Music
  • Site Owners Choice
  • Parkinsons
    • Parkinsons News
    • Homeless
  • Domapine Agonists
    • Add your Agonist Story
    • Show Agonist Stories
  • Login and Register
Select Page
Phase 2 Trial of KM-819 Recruiting Patients After Promising Safety Data

Phase 2 Trial of KM-819 Recruiting Patients After Promising Safety Data

by Parkinsons News Today | Jan 14, 2023 | Parkinsons

Increasing doses of KM-819, a potential therapy being developed by Fascinate Therapeutics for Parkinson’s disease, showed a favorable safety profile in healthy older adults, according to data from the now-completed Part 1a of a Phase 2

Categories

  • Yelp
  • Facebook
  • Twitter
  • Instagram
  • Email
  • Privacy Policy
  • Facebook
  • Twitter
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress